Omega Diagnostics, a medical testing company, has reported greater interim losses despite an increase in revenues.
Omega Diagnostics, a medical testing company, has reported greater interim losses despite an increase in revenues.
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2021
Zak Mir takes a technical perspective on some of the most followed small caps on the London market. Today’s selection includes Brandshield, Galileo, Insig AI, Novacyt, Omega Diagnostics, Pantheon, Red
Zak Mir takes a technical analysis perspective on some of the most followed small caps on the London market. Today’s selection includes Asiamet Resources, Bezant Resources, Chesterfield Resources, Global Petroleum,
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Global Health (CD4 and COVID-19) and Health and Nutrition products, announces it will release its interim results for the
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Global Health (CD4 and COVID-19) and Health and Nutrition products, notes the UK Health Security Agency’s Medical Devices (Coronavirus
Agreement for Omega’s Market Leading, UK Manufactured VISITECT ® COVID-19 Antigen LFT
While some in the market are still waiting on M&A with regard to Eurasia Mining (EUA), the PGM and battery metals specialist unveiled a detailed mining plan has been completed
Omega (AIM: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, will hold its Annual General Meeting (‘AGM’) today at 11am at Omega
All supporting data and documentation now submitted to Omega’s European Notified Body
Omega (AIM: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, announces that the Notice of Annual General Meeting (‘AGM’).
AbC-19TM test to monitor vaccine responses to variants of concern AbC-19TM able to detect antibody response to different vaccines as well as natural infection